These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7650220)

  • 21. Albumin excretion rate and metabolic modifications in patients with essential hypertension. Effects of two angiotensin converting enzyme inhibitors.
    Puig JG; Mateos FA; Ramos TH; Lavilla MP; Capitán MC; Gil A
    Am J Hypertens; 1994 Jan; 7(1):46-51. PubMed ID: 8136110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.
    Kaur P; Muthuraman A; Kaur M
    ACS Chem Neurosci; 2015 Apr; 6(4):508-21. PubMed ID: 25680080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of the clinical development of quinapril.
    Frank GJ
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII13-8. PubMed ID: 2189616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New angiotensin converting enzyme inhibitors. Their role in the management of hypertension.
    Laragh JH
    Am J Hypertens; 1990 Nov; 3(11):257S-265S. PubMed ID: 2261144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Therapy of hypertension with ACE inhibitors. One third fewer cases of diabetes].
    MMW Fortschr Med; 2002 Mar; 144(10):63. PubMed ID: 11928273
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin-Converting Enzyme Inhibitors in Hypertension: To Use or Not to Use?
    Messerli FH; Bangalore S; Bavishi C; Rimoldi SF
    J Am Coll Cardiol; 2018 Apr; 71(13):1474-1482. PubMed ID: 29598869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiotensin-converting enzyme inhibitors for intermittent claudication associated with peripheral arterial disease.
    Hunter MR; Cahoon WD; Lowe DK
    Ann Pharmacother; 2013 Nov; 47(11):1552-7. PubMed ID: 24285767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of the converting enzyme inhibitor quinapril (CI-906) on blood pressure, renin-angiotensin system, and prostanoids in essential hypertension.
    Säynävälammi P; Pörsti I; Pörsti P; Nurmi AK; Seppälä E; Manninen V; Vapaatalo H
    J Cardiovasc Pharmacol; 1988 Jul; 12(1):88-93. PubMed ID: 2459540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril.
    Skowasch D; Viktor A; Schneider-Schmitt M; Lüderitz B; Nickenig G; Bauriedel G
    Clin Res Cardiol; 2006 Apr; 95(4):212-6. PubMed ID: 16598590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Russian study of efficacy and safety of an angiotensin converting enzyme inhibitor quinapril in patients with hypertension].
    Karpov IuA; Deev AD;
    Kardiologiia; 2003; 43(6):28-32. PubMed ID: 12891308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin-converting enzyme in cardiovascular and adrenal tissues and implications for successful blood pressure management.
    Melby JC
    Am J Cardiol; 1992 Apr; 69(10):2C-7C. PubMed ID: 1546636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Angiotensin-converting-enzyme inhibition in arterial hypertension].
    Waeber B; Nussberger J; Brunner HR
    Wien Med Wochenschr; 1990 Jan; 140(1-2):22-30. PubMed ID: 2408247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An open multicenter study to assess the long-term efficacy, tolerance, and safety of the oral angiotensin converting enzyme inhibitor ramipril in patients with mild to moderate essential hypertension.
    Bauer B; Lorenz H; Zahlten R
    J Cardiovasc Pharmacol; 1989; 13 Suppl 3():S70-4. PubMed ID: 2474109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety profile of benazepril in essential hypertension.
    MacNab M; Mallows S
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV33-7; discussion IV51-5. PubMed ID: 1893640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin converting enzyme inhibitors: differences and advantages for first line therapy in hypertension.
    Johnston CI
    Clin Exp Hypertens A; 1989; 11(5-6):1097-115. PubMed ID: 2676252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.